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Sickle cell nephropathy (SCN) is a chronic manifestation of sickle
cell disease (SCD). We previously found that reactive oxygen species
(ROS) were elevated in the glomeruli from SCD mice. Importantly,
treatment with ABT-627, a selective ET-A receptor antagonist, re-
duced glomerular ROS production in SCD mice to levels observed in
controls. Because SCN is thought to progress secondary to repeated
occlusions in the microvasculature, we hypothesized that hypoxia
stimulates the production of glomerular ET-1, causing deleterious
effects through over-production of ROS. To directly test if ET-1 is
increased in response to hypoxia in unaffected mice, we exposed
vascular endothelial ET-1 knockout (VEET) mice and ﬂoxed controls
to normoxia or 3 h of hypoxia (8% O2). In response to hypoxia, ﬂoxed
mice had signiﬁcant increases in glomerular ET-1 mRNA while there
was no response to hypoxia in the VEETmice, indicating that hypoxia
stimulates endothelial-derived glomerular ET-1 (ﬂoxed hypoxia:
2.1 ± 0.2, ﬂoxed normoxia: 1.1 ± 0.2, VEET hypoxia: 0.7 ± 0.1, VEET
normoxia: 0.8 ± 0.3 fold change, p b 0.01, n = 6/group). To deter-
mine the inﬂuence of chronically elevated ET-1 on glomerular ROS
production, C57BL/6J mice were treated with saline or ET-1 (2 weeks
@2 pg/kg/day) via a miniosmotic pump. Mice treated with ET-1
demonstrated signiﬁcant increases in stimulated ROS production
compared to saline controls (5452 ± 655 vs. 2177 ± 359 luminescence/
protein∗min, p b 0.01, n = 5–6). These data reveal that hypoxia leads
to upregulation of endothelial-derived glomerular ET-1 and that chronic
elevations in ET-1, similar to what is seen in SCD, increase ROS pro-
duction in the glomeruli. Taken together, these data identify a novel
mechanism by which hypoxia stimulates the upregulation of ET-1 in
glomerular endothelial cells and promotes glomerular ROS production.
doi:10.1016/j.lfs.2013.12.079
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Hypertension plays a critical role in the progression of chronic
kidney disease (CKD). Recent studies have shown that besides the
inappropriately activated renin–angiotensin system (RAS), enhanced
intrarenal activity of the endothelin (ET) system via activation of ET
receptor type A (ETA) contributes to the pathophysiology of hyper-
tension and progression of CKD. We therefore evaluated whether
addition of selective ETA receptor blockade to the standard RAS
blockade will exhibit additional beneﬁcial effects on the progression
of CKD. Ren-2 transgenic rats (TGR) underwent 5/6 renal ablation
(5/6 NX) serving as model of CKD. A combination of angiotensin-
converting enzyme inhibitor (trandolapril, 6 mg/l drinking water) and
angiotensin II receptor blocker (losartan, 100 mg/l drinking water)
was used. ETA receptor blocker (atrasentan, 5 mg·kg−1·day−1) was
employed with the combination of RAS blockade. The follow-up period
was 44 weeks after 5/6 NX. The following parameters were evaluated:
survival rate, systolic blood pressure (SBP), proteinuria and renal glo-
merular damage. Both therapeutical regimes improved survival rate,
however the efﬁciency of isolated RAS blockade considerably decreased
at 36 weeks after 5/6 NX (ﬁnal survival rate was 65%). The combined
RAS and ETA receptor blockade exhibited a ﬁnal survival rate of 91%,
which was signiﬁcantly better as compared with isolated RAS in-
hibition, even if there were no signiﬁcant differences in SBP among the
experimental groups. In addition, the RAS and ETA receptor blockade
further reduced proteinuria and renal glomerular damage. Our data
show that a combined RAS and ETA receptor blockade exhibited
additional beneﬁcial effects on the progression of CKD in 5/6 NX TGR as
compared with isolated RAS inhibition.
doi:10.1016/j.lfs.2013.12.080
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Septic acute kidney injury (AKI) remains associated with high
mortality rate, partially, because of the poor understanding of its
(patho)physiology. Endothelin-1 (ET-1), which is produced and is
secreted from vascular endothelium, plays important roles on renal
hemodynamics via autocrine/paracrine and, possibly, hormonal mech-
anisms. Previous studies have demonstrated that either selective or
non-selective endothelin antagonists attenuate the hemodynamic
changes in experimental sepsis models. Thus, we investigated the role
of endothelial cell-derived ET-1 on the severity of lipopolysaccharide
(LPS)-induced AKI by using endothelial cell-speciﬁc ET-1 knock-out
mice (VEETKO). The renal microcirculation dynamics was observed by
intravital 2-photon laser microscopy. LPS (from Escherichia coli O55:B5,
5 mg/kg, i.p.) increased leukocyte attachment in the capillary walls,
whereas there was maintained plasma ﬂow in the peritubular capillar-
ies in VEETKO. The urine ﬂow rate was reduced to half in VEETKO
compared with that in normal (LPS-untreated) C57B6 mice, while the
blood urea nitrogen level was still at normal level in VEETKO (22.8 ±
0.2 mg/dL vs. 52.9 ± 12.7 mg/dL in C57B6) at 24 h after LPS injection.
Fluid resuscitation (1.5 mL of saline, s.c., at 6 and 14 h after LPS)
normalized the LPS-induced increase in leukocyte attachment and the
decrease in urine ﬂow rate in VEETKO, but the effects were partial in
C57B6 mice. These results suggest that VEETKO kidney is less sensitive
against endotoxemia than the kidney of C57B6mice, and that leukocyte
attachment and reduction of urine ﬂow in VEETKO may be due to the
decrease in blood pressure by endotoxemia in combination with the
lack of ET-1.
doi:10.1016/j.lfs.2013.12.081
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Endothelin-1 (ET-1) has been shown to have an important role
in diabetic nephropathy (DN). Here we investigated the contribution
of endothelial cell-derived ET-1 to the changes in renal phenotype
of diabetic mice. Therefore, we induced type 1 diabetes in vascular
endothelial cell-speciﬁc ET-1 knockout (VEETKO) mice and their wild
type (WT) littermates by streptozotocin injection (i.p. 50 mg/kg/day,
ﬁve consecutive days). After ten and 22 weeks of diabetes, we observed
an increase of food and water intake, urine volume and creatinine
clearance in both genotypes compared to non-diabetic mice. The renal
cortical expression of ET-1 mRNA was not signiﬁcantly activated by
diabetes. Nevertheless, VEETKO mice showed only about half of ET-1
mRNA expression compared to WT mice. Though, there were no sig-
niﬁcant differences in the renal function including albumin and protein
excretion between the genotypes. Based on hematocrit measurements,
neither diabetes nor ET-1 deﬁciency had an impact on ﬂuid retention.
After ten weeks of diabetes, systolic blood pressure measured by tail-
cuff method decreased in WT mice. After 22 weeks, heart rate and
systolic and diastolic blood pressurewere similar between all groups. At
baseline the kidneys of VEETKOmicewere signiﬁcantly heavier (+15%)
compared to WT mice but this gap was not observed in diabetic
condition. In contrast to previously presented data, in thismodel of type
1 diabetes we are not able to conﬁrm the pivotal role of endothelial cell
derived ET in the development of DN.
doi:10.1016/j.lfs.2013.12.082
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Background: Endothelin receptor antagonists reduce albuminuria
in diabetic patients. However, adverse effects related to ﬂuid retention
and attributed to the blocking of the tubular endothelin receptors
prevent the use of ERA clinically. The endothelin A (ETA) receptors
on podocytes might be implicated in albuminuria during diabetes.
We hypothesized that the suppression of the ETA receptors on the
podocytes may reduce albuminuria without affecting the tubular func-
tions. Methods and results: To address this question, we generated
podocyte speciﬁc ETA deﬁcient mice using ETA ﬂoxedmice matedwith
mice expressing the Cre recombinase under the control of the nephrin
gene (PodoETAKO mice). We induced type-1 diabetes in seven-week
old male PodoETAKO mice and their wild type (WT) littermates by
streptozotocin injection (i.p. 50 mg/kg/day, ﬁve consecutive days). A set
of animals were treated with macitentan, a dual ETA/ETB antagonist
(25 mg/kg/day, orally, mixed with food). The hyperglycemic mice
developed glomerular hyperﬁltration, renal hypertrophy, reduced serum
creatinine levels, albuminuria, tubular injury, glomerular hypertrophy
and inﬂammation. After 20 weeks of diabetes, the absence of ETA
receptors on podocytes had no effect on these parameters. Macitentan
treatment however reduced albuminuria and restored serum creatinine
levels in wild type mice. Interestingly, the effects of macitentan were
diminished in PodoETAKO mice. Similarly, macitentan increased
podocyte number per glomerulus (WT-1 positive cells) and glomerulus
size in WT but not in PodoETAKO mice. Neither ETA deﬁciency nor
macitentan treatment increased water retentionmeasured as free water
clearance. Conclusion: In contrast to systemic dual ETA/ETB receptor
blockade, the suppression of the ETA receptors on podocytes is not
antialbuminuric in diabetic mice.
doi:10.1016/j.lfs.2013.12.083
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Retinitis pigmentosa (RP) is an inherited retinal disorder char-
acterized by bone spicul pigment in the retina, attenuated retinal
blood vessels and a pale, waxy optic nerve head with early visual
ﬁeld contraction and decrease of the electroretinogram (ERG). Retinal
hemodynamic impairment is still present in early stages of RP and
various hypotheses have been advanced as to a cause. We studied
with multifocal electroretinogram (mfERG) of the macula and optical
coherence tomography (OCT) of the choroid 24 patients, 14 males and
10 females, aged 63–45 yrs. (mean 55 ± 7 yrs.) and affected by simplex
RP. The patients had a visual acuity of 0.1 log MAR with a mean defect
(MD) of the visual ﬁeld of −12.32 ± 8.48 dB, a pattern standard
deviation index (PSD) of 6.09 ± 4.22 dB and a b-wave electroretino-
gram (ERG) amplitude of 45.08 ± 8.24 &muV. An increase of endo-
thelin-1 (ET-1) plasma levels was found: 2.143 ± 0.258 pg/ml vs.
1.219 ± 0.236 pg/ml in non-RP controls (p b 0.002). The choroidal
thickness was 226.75 ± 76.37 μ vs. 303.9 ± 39.87 μ (p b 0.002) in
normal controls. The Spearman's correlation test highlighted that the
decrease of choroidal thickness (r =−0.702; p b 0.023) and the in-
crease of time latency in the rings 2 (r =−0.669; p b 0.034) and 3
(r = -0.883; p b 0.007) of mfERG were related to the increase of ET-1
plasma levels. It is thought that an increase in ET-1 in our RP could lead
to a vasoconstriction in the choroidal vessels and worsening the
abiotrophic process of the macular photoreceptors with increase of the
conduction implicit time.
doi:10.1016/j.lfs.2013.12.084
Clinical value of plasma pentraxin 3 levels for predicting cardiac
troponin elevation after percutaneous coronary intervention
Zheng Wanga, Akira Satob, Taizo Kimurab, Kazuko Tajirib,
Tomoya Hoshib, Satoshi Sakaib, Akira Koikeb,
Takashi Miyauchib, Kazutaka Aonumab
aCardiovascular Division, Graduate School of Comprehensive Human
Sciences, University of Tsukuba, Japan
bCardiovascular Division, Faculty of Medicine, University of Tsukuba,
Tsukuba, Japan
E-mail address: asato@md.tsukuba.ac.jp (Z. Wang)
Background: Percutaneous coronary intervention (PCI) is often
complicated by post-procedural myocardial necrosis as manifested
by elevated cardiac troponin. Plasma pentraxin 3 (PTX3) levels are
increased in patients with arterial inﬂammation, especially unstable
angina pectoris (AP). The study tested whether plasma PTX3 levels
can predict post-PCI cardiac troponin T (TnT) elevation. Methods:
We evaluated 94 consecutive patients with AP of normal pre-PCI TnT
levels who underwent PCI. Pre-PCI virtual histology-intravascular
ultrasound was performed to assess culprit plaque composition.
Abstracts e19
